BSE Live
Mar 11, 16:01Prev. Close
55.20
Open Price
52.44
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Trident Texofab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 13.56 | 10.07 | 10.07 | 10.07 | 10.07 | |
| Total Share Capital | 13.56 | 10.07 | 10.07 | 10.07 | 10.07 | |
| Reserves and Surplus | 29.57 | 6.19 | 5.11 | 2.89 | 1.91 | |
| Total Reserves and Surplus | 29.57 | 6.19 | 5.11 | 2.89 | 1.91 | |
| Total Shareholders Funds | 47.24 | 16.26 | 15.18 | 12.96 | 11.98 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 7.43 | 17.74 | 18.58 | 20.27 | 19.19 | |
| Deferred Tax Liabilities [Net] | 0.54 | 1.11 | 1.38 | 0.97 | 0.68 | |
| Other Long Term Liabilities | 4.62 | 4.51 | 4.93 | 6.54 | 5.68 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 12.59 | 23.36 | 24.89 | 27.78 | 25.54 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 19.07 | 19.23 | 16.07 | 15.72 | 9.96 | |
| Trade Payables | 14.86 | 16.69 | 17.62 | 11.39 | 16.22 | |
| Other Current Liabilities | 3.30 | 3.71 | 1.63 | 1.32 | 3.17 | |
| Short Term Provisions | 3.53 | 2.65 | 1.91 | 1.82 | 0.91 | |
| Total Current Liabilities | 40.75 | 42.28 | 37.23 | 30.25 | 30.25 | |
| Total Capital And Liabilities | 100.58 | 81.90 | 77.31 | 70.99 | 67.77 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 20.09 | 21.73 | 23.33 | 21.71 | 14.21 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 3.62 | 8.89 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 20.09 | 21.73 | 23.33 | 25.33 | 23.11 | |
| Non-Current Investments | 1.89 | 3.74 | 3.64 | 2.06 | 2.48 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Other Non-Current Assets | 4.85 | 4.32 | 3.65 | 3.57 | 2.17 | |
| Total Non-Current Assets | 26.83 | 29.79 | 30.62 | 30.96 | 27.78 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 15.96 | 13.55 | 10.64 | 7.27 | 8.01 | |
| Trade Receivables | 40.71 | 36.67 | 33.87 | 30.85 | 30.28 | |
| Cash And Cash Equivalents | 3.16 | 0.16 | 0.06 | 0.04 | 0.03 | |
| Short Term Loans And Advances | 1.25 | 0.00 | 0.00 | 0.00 | 0.09 | |
| OtherCurrentAssets | 12.67 | 1.73 | 2.11 | 1.86 | 1.58 | |
| Total Current Assets | 73.74 | 52.10 | 46.69 | 40.03 | 40.00 | |
| Total Assets | 100.58 | 81.90 | 77.31 | 70.99 | 67.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.05 | 1.44 | 1.44 | 1.44 | 1.44 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.04 | 0.11 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 8.20 | 8.20 | 8.20 | 8.20 | 8.20 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 1.89 | 3.74 | 3.64 | 2.06 | 2.48 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.02.2026
Trident Standalone December 2025 Net Sales at Rs 1,565.80 crore, down 5.82% Y-o-Y
20.02.2026
Trident Consolidated December 2025 Net Sales at Rs 1,574.46 crore, down 5.56% Y-o-Y
20.01.2026
Trident Lifelin Consolidated December 2025 Net Sales at Rs 25.71 crore, up 117.4% Y-o-Y
20.01.2026
Trident Lifelin Standalone December 2025 Net Sales at Rs 23.67 crore, up 43.38% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
11.03.2026
Apsis Aerocom IPO sees over 3 times subscription on day 1 despite subdued market sentiment
11.03.2026
Iranian drones hit Oman’s Salalah port fuel tanks amid rising gulf tensions | Watch
11.03.2026
Trump keeps gifting staff Rs 13,000 shoes and 'everyone’s afraid not to wear them'
11.03.2026
17.07.2019
What does Finesse partnership mean for Aditya Birla Fashion and Retail?
12.06.2019
Will Jaypore, TG Apparel be a good fit for Aditya Birla Fashion and Retail?
02.05.2019
Are buy-backs an easy way for investors to make a quick buck?
04.12.2018
Here’s how engineering cos reinvent their biz as opportunities shrink